Danaher Corporation (DHR)

246.93 +0.62 (+0.25%) At close: 04:03PM EDT

Danaher Corporation

2200 Pennsylvania Avenue, NW
Suite 800W
Washington, DC 20037-1701
United States
202 828 0850
https://www.danaher.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 81,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Steven M. Rales	Co-Founder & Chairman	N/A	N/A	1951
Mr. Rainer M. Blair	Pres, CEO & Director	5.77M	N/A	1964
Mr. Mitchell P. Rales	Co-Founder & Director	N/A	N/A	1957
Mr. Matthew R. McGrew	CFO & Exec. VP	2.68M	3.04M	1972
Mr. Joakim Weidemanis	Exec. VP	3.06M	2.35M	1969
Ms. Jennifer L. Honeycutt	Exec. VP	2.44M	N/A	1970
Mr. Christopher M. Bouda	Chief Accounting Officer	N/A	N/A	N/A
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.	Sr. VP & Chief Science Officer	N/A	N/A	1964
Mr. John Bedford	VP of Investor Relations	N/A	N/A	N/A
Mr. Brian W. Ellis	Sr. VP, Gen. Counsel & Chief Compliance Officer	N/A	N/A	1967

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Corporate governance

Danaher Corporation’s ISS governance QualityScore as of 1 February 2023 is 3. The pillar scores are Audit: 7; Board: 7; Shareholder rights: 3; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.